Selective Cyclo-Oxygenase-2 Inhibitors and Myocardial Infarction: How Strong is the Link?

ISSN： 0114-5916

Source： Drug Safety, Vol.25, Iss.12, 2002-01, pp. : 829-835

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Do Selective Cyclo-Oxygenase-2 Inhibitors Have a Future?

By Bannwarth Bernard

Drug Safety, Vol. 28, Iss. 3, 2005-01 ,pp. : 183-189

Adis International

Access to resources Recommend Favorite

Is there a Future for Cyclo-Oxygenase Inhibitors in Alzheimer's Disease?

By Ho Lap Qin Weiping Stetka Breton S. Pasinetti Giulio M.

CNS Drugs, Vol. 20, Iss. 2, 2006-01 ,pp. : 85-98

Adis International

Access to resources Recommend Favorite

Cyclo-Oxygenase-2 Inhibitors: When Should They Be Used in the Elderly?

By Savage Ruth

Drugs & Aging, Vol. 22, Iss. 3, 2005-01 ,pp. : 185-200

Adis International

Access to resources Recommend Favorite

Cyclo-Oxygenase-2 and its Inhibition in Cancer: Is There a Role?

By Liao Zhongxing

Drugs, Vol. 67, Iss. 6, 2007-01 ,pp. : 821-845

Adis International

Access to resources Recommend Favorite

Balancing Gastroprotection and Cardioprotection with Selective Cyclo-Oxygenase-2 Inhibitors: Clinical Implications

By Meagher E.A.

Drug Safety, Vol. 26, Iss. 13, 2003-01 ,pp. : 913-924

Adis International

Access to resources Recommend Favorite